Virtual Clinical Trials, are not a new concept, but have experienced a boost during COVID-19. The pandemic has pushed pharma companies to increase adoption of virtual trials, as patient feels insecure when visiting sites.
Going virtual with your clinical trial can boost a lot of postives. It enable fewer on-site visits for the patient or eliminate them completely. The patient base can widen over a larger area as there is no need to go to a site and with app and email reminders the patient adherence can be increased.
However going virtual is not a “one-size fits all” solution. In This white paper we will take a closer look at some of the pitfalls when planning a virtual trial.